CSK Tri-Axis Balanced Series I-IV

Mentha × piperita

Peppermint

Tier ICSK Tri-Axis Balanced Series

Target Trait

1×

fold-change

Cooling+Sweet+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02204

Genomic Edits

GC Content

43.9%

Construct Length

3,913 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPM8 + TAS1R2/TAS1R3 + CaSR

IFI Score

100

Pathway Edits

TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent CSK pathway operation
Cross-pathway regulatory circuit for balanced CSK triple-axis expression

Key Interventions

Triple-axis receptor co-activation: TRPM8, TAS1R2/TAS1R3, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (CSK) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier I CSK triple-axis construct for advanced multi-modal sensory architecture combining cooling, sweet, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities